close

Biofil Chemicals & Pharmaceuticals Ltd

Know More
NSEBSE

49.35-0.20 (-0.40%)

12:00 AM,22nd Sep 2023

49.22-0.28 (-0.57%)

12:00 AM,22nd Sep 2023

BSE : 524396

NSE : BIOFILCHEM

Sector : Health care

ISIN Code : INE829A01014

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Sep 22 2023 | 12:00 AM IST

Market Cap (₹ Cr)

80

Turnover (₹ Cr)

0.01

Volume (Shares)

19338

Face Value

10

52-WK High

65.00

52-WK High Date

26 Dec 2022

52-WK Low

39.30

52-WK Low Date

28 Mar 2023

All Time High

356.10

All Time High Date

14 Dec 2020

All Time Low

0.55

All Time Low Date

17 Jul 1998

Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals (BCPL) was incorporated as a private limited company on 4 Jan.'85 for manufacture of pharmaceutical products and it was converted into a public limited company on 7 May '92. It was promoted by the Systematix group and Ramesh Shah of the Cyano group. Ramesh Shah is the chairman and managing director and Anand Kumar Sethiya is the managing director. In Feb.'96 the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively both aggregating Rs 23.21 cr to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections capsules eye-drops and dry syrups at its plant located in Indore. BCPL's new unit is being set up at Pithampur in Madhya Pradesh at a project cost of Rs 39.75 cr and will manufacture bulk drugs like astemizole cefaclor pentazocine cefazolin sodium and cefotoxime sodium. It is also setting up a R&D centre which will include a pilot plant for bulk drugs and separate sections for formulations development and will house modern analytical instruments.During the year 1999-2000 the company had achieved a turnover of Rs.1164.03 lakhs.

Biofil Chemicals & Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

80

EPS - TTM (₹) [S]

0.37

P/E Ratio (X) [S]

4.64

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]10.63
P/B Ratio (₹) [S]4.64
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

49.10

50.40

Week Low/High

48.15

54.00

Month Low/High

45.05

54.00

Year Low/High

39.30

65.00

All time Low/High

0.30

356.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-4.95%-5.00%-2.70-2.57%
1 Month6.63%6.82%1.211.43%
3 Month11.53%11.78%4.384.81%
6 Month16.25%17.22%13.6615.00%
1 Year-1.50%-1.89%11.6511.60%
3 Year-8.10%-9.86%74.9376.39%

Financials

Graph
Table

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
18-11-2022MOHINI DOSHINSESELL10034959.11
18-11-2022MOHINI DOSHINSEBUY10034959.23
18-11-2022SILVER LINE VENTURES PRIVATE LIMITEDNSESELL9700459.18
18-11-2022SILVER LINE VENTURES PRIVATE LIMITEDNSEBUY9700458.67
11-01-2022ALPHA LEON ENTERPRISES LLPNSEBUY12511997.40
11-01-2022ALPHA LEON ENTERPRISES LLPNSESELL13445797.75
11-01-2022DB (INTL) OWN TRADINGBSEBUY2540596.60
11-01-2022DB (INTL) OWN TRADINGBSESELL8340397.59
11-01-2022DB INTERNATIONAL STOCK BROKERS LIMITEDNSESELL2540596.60
11-01-2022DB INTERNATIONAL STOCK BROKERS LIMITEDNSEBUY8340397.40

Load More

Peer Group Comparison

NamePrice(In Rs)Chg(%)Mkt Cap(Rs Cr)Sales(Rs Cr)Profit(Rs Cr)EPS(Rs)P/E(x)

Shareholding Pattern

Jun 2023
Archive
CategoryShare(%)
Promoter46.82
Financial Institutions Banks0.04
Foreign Institutional Investors0.00
Insurance Companies0.00
Mutual Funds Uti0.00
Other Institutional Investors0.04
Indian Public38.10
Others Non Institutional Investors15.00
Custodians0.00

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

Chairman & Managing Director : Ramesh Shah

Director : Romil Shah

Independent Director : Shaila Jain

Independent Director : Satish Beohar

Independent Director : Ashok Kumar Ramawat

Whole-time Director : Ketan Shah

Company Sec. & Compli. Officer : Shweta Verma

Registered Office: 11/12 Sector E Sanwer Road, Sanwer Road Industrial Area,Indore,Madhya Pradesh-452015 Ph: 91-731-2426700

Email:bcplcompliance@gmail.com

URL:http://www.biofilgroup.net